Corrigendum: Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

Fatemeh Yazarlou; Ivan Martinez; Leonard Lipovich

doi:10.3389/fonc.2024.1507032

Corrigendum: Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance

Front Oncol. 2024 Dec 11:14:1507032. doi: 10.3389/fonc.2024.1507032. eCollection 2024.

Authors

Fatemeh Yazarlou¹, Ivan Martinez², Leonard Lipovich^{3

4

5

6

7}

Affiliations

¹ Center for Childhood Cancer, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.
² Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV, United States.
³ Department of Biology, College of Science, Mathematics, and Technology, Wenzhou-Kean University, Wenzhou, China.
⁴ Wenzhou Municipal Key Laboratory for Applied Biomedical and Biopharmaceutical Informatics, Wenzhou-Kean University, Wenzhou, China.
⁵ Zhejiang Bioinformatics International Science and Technology Cooperation Center, Wenzhou-Kean University, Wenzhou, China.
⁶ Shenzhen Huayuan Biological Science Research Institute, Shenzhen Huayuan Biotechnology Co. Ltd., Shenzhen, China.
⁷ Center for Molecular Medicine and Genetics, School of Medicine, Wayne State University, Detroit, MI, United States.

Abstract

[This corrects the article DOI: 10.3389/fonc.2024.1437542.].

Keywords: breast neoplasms; genomics; long non-coding RNAs; non-coding RNAs; precision medicine; radioresistance; radiosensitivity; radiotherapy.

Publication types

Published Erratum

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Leonard Lipovich, PhD, was funded by the Wenzhou-Kean University faculty start-up research grant, the Wenzhou Municipal Key Laboratory for Applied Biomedical and the Biopharmaceutical Informatics (WB20211227000125), and the Zhejiang Bioinformatics International Science and Technology Cooperation Center at Wenzhou-Kean University (WB20210429000008). Ivan Martinez, PhD, was supported by Research Scholar Grants RSG-24-1039619-01-RMC and DOI 1039619 from the American Cancer Society.